Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-01 4:54 pm Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | BlackRock Inc. BLK | 986,572 5.8% | 37,045 (+3.90%) | View |
| 2022-05-19 4:10 pm Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Deep Track Capital, LP | 917,825 5.37% | 917,825 (New Position) | View |
| 2022-02-14 6:31 pm Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | ARMISTICE CAPITAL, LLC | 1,124,000 6.6% | 1,124,000 (New Position) | View |
| 2022-02-14 10:31 am Sale | 13G | Madrigal Pharmaceuticals, Inc. MDGL | HealthCor Management, L.P. | 0 0% | -902,601 (Position Closed) | View |
| 2022-02-11 10:03 am Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Avoro Capital Advisors LLC | 1,425,000 8.3% | 200,000 (+16.33%) | View |
| 2022-02-10 08:22 am Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | VANGUARD GROUP INC | 1,123,061 6.57% | 234,643 (+26.41%) | View |
| 2022-02-04 09:29 am Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | WELLINGTON MANAGEMENT GROUP LLP | 1,320,795 7.73% | 404,903 (+44.21%) | View |
| 2022-02-02 7:18 pm Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | BlackRock Inc. BLK | 949,527 5.6% | 5,109 (+0.54%) | View |
| 2021-12-07 4:30 pm Sale | 13D | Madrigal Pharmaceuticals, Inc. MDGL | BAY CITY CAPITAL LLC | 2,037,140 11.9% | -826,934 (-28.87%) | View |
| 2021-07-09 12:27 pm Sale | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Capital Research Global Investors | 466,422 2.8% | -1,424,365 (-75.33%) | View |
| 2021-02-16 4:58 pm Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | BAKER BROS. ADVISORS LP | 1,499,213 9.7% | 329,935 (+28.22%) | View |
| 2021-02-16 1:27 pm Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Capital Research Global Investors | 1,890,787 12.2% | 193,668 (+11.41%) | View |
| 2021-02-12 4:10 pm Sale | 13G | Madrigal Pharmaceuticals, Inc. MDGL | HealthCor Management, L.P. | 902,601 5.8% | -185,709 (-17.06%) | View |
| 2021-02-12 08:06 am Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Avoro Capital Advisors LLC | 1,225,000 7.9% | 1,225,000 (New Position) | View |
| 2021-02-10 11:22 am Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | VANGUARD GROUP INC | 888,418 5.74% | 102,977 (+13.11%) | View |
| 2021-02-04 11:31 am Sale | 13G | Madrigal Pharmaceuticals, Inc. MDGL | WELLINGTON MANAGEMENT GROUP LLP | 915,892 5.92% | -41,254 (-4.31%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | BlackRock Inc. BLK | 944,418 6.1% | 944,418 (New Position) | View |
| 2020-09-04 9:16 pm Sale | 13D | Madrigal Pharmaceuticals, Inc. MDGL | BAY CITY CAPITAL LLC | 2,864,074 18.6% | -1,441,005 (-33.47%) | View |
| 2020-06-01 5:19 pm Purchase | 13D | Madrigal Pharmaceuticals, Inc. MDGL | BAY CITY CAPITAL LLC | 4,305,079 27.9% | 127,225 (+3.05%) | View |
| 2020-02-14 12:03 pm Purchase | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Capital Research Global Investors | 1,697,119 10.9% | 32,667 (+1.96%) | View |